Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Intervalo de año de publicación
1.
J Biol Chem ; 289(41): 28284-98, 2014 Oct 10.
Artículo en Inglés | MEDLINE | ID: mdl-25147180

RESUMEN

Fucosylated chondroitin sulfate (fCS) extracted from the sea cucumber Holothuria forskali is composed of the following repeating trisaccharide unit: → 3)GalNAcß4,6S(1 → 4) [FucαX(1 → 3)]GlcAß(1 →, where X stands for different sulfation patterns of fucose (X = 3,4S (46%), 2,4S (39%), and 4S (15%)). As revealed by NMR and molecular dynamics simulations, the fCS repeating unit adopts a conformation similar to that of the Le(x) blood group determinant, bringing several sulfate groups into close proximity and creating large negative patches distributed along the helical skeleton of the CS backbone. This may explain the high affinity of fCS oligosaccharides for L- and P-selectins as determined by microarray binding of fCS oligosaccharides prepared by Cu(2+)-catalyzed Fenton-type and photochemical depolymerization. No binding to E-selectin was observed. fCS poly- and oligosaccharides display low cytotoxicity in vitro, inhibit human neutrophil elastase activity, and inhibit the migration of neutrophils through an endothelial cell layer in vitro. Although the polysaccharide showed some anti-coagulant activity, small oligosaccharide fCS fragments had much reduced anticoagulant properties, with activity mainly via heparin cofactor II. The fCS polysaccharides showed prekallikrein activation comparable with dextran sulfate, whereas the fCS oligosaccharides caused almost no effect. The H. forskali fCS oligosaccharides were also tested in a mouse peritoneal inflammation model, where they caused a reduction in neutrophil infiltration. Overall, the data presented support the action of fCS as an inhibitor of selectin interactions, which play vital roles in inflammation and metastasis progression. Future studies of fCS-selectin interaction using fCS fragments or their mimetics may open new avenues for therapeutic intervention.


Asunto(s)
Antiinflamatorios no Esteroideos/química , Sulfatos de Condroitina/química , Enfermedades del Sistema Inmune/tratamiento farmacológico , Trastornos Leucocíticos/tratamiento farmacológico , Peritonitis/tratamiento farmacológico , Proteínas Inhibidoras de Proteinasas Secretoras/química , Pepinos de Mar/química , Animales , Antiinflamatorios no Esteroideos/aislamiento & purificación , Antiinflamatorios no Esteroideos/metabolismo , Antiinflamatorios no Esteroideos/farmacología , Conformación de Carbohidratos , Sulfatos de Condroitina/aislamiento & purificación , Sulfatos de Condroitina/metabolismo , Sulfatos de Condroitina/farmacología , Peróxido de Hidrógeno , Enfermedades del Sistema Inmune/metabolismo , Enfermedades del Sistema Inmune/patología , Hierro , Selectina L/química , Selectina L/metabolismo , Trastornos Leucocíticos/metabolismo , Trastornos Leucocíticos/patología , Elastasa de Leucocito/antagonistas & inhibidores , Elastasa de Leucocito/metabolismo , Ratones , Modelos Moleculares , Datos de Secuencia Molecular , Infiltración Neutrófila/efectos de los fármacos , Neutrófilos/efectos de los fármacos , Neutrófilos/metabolismo , Neutrófilos/patología , Oxidación-Reducción , Selectina-P/química , Selectina-P/metabolismo , Peritonitis/metabolismo , Peritonitis/patología , Proteínas Inhibidoras de Proteinasas Secretoras/aislamiento & purificación , Proteínas Inhibidoras de Proteinasas Secretoras/metabolismo , Proteínas Inhibidoras de Proteinasas Secretoras/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA